氯碱B股(900908) - 2021 Q1 - 季度财报
SCACSCAC(SH:900908)2021-04-27 16:00

Financial Performance - Net profit attributable to shareholders increased by 292.04% to CNY 345,585,062.88 compared to the same period last year[8] - Operating revenue rose by 34.63% to CNY 1,547,218,556.09 year-on-year[8] - Basic earnings per share increased by 292.13% to CNY 0.2988[8] - The net profit after deducting non-recurring gains and losses was CNY 346,718,183.23, reflecting a 290.35% increase year-on-year[8] - Net profit for Q1 2021 was ¥345,075,189.54, representing a 292.05% increase from ¥88,018,207.15 in the same period last year[18] - Operating profit for Q1 2021 reached CNY 392 million, compared to CNY 102 million in the same period last year, reflecting a significant growth[30] - The company reported a net profit increase, with retained earnings rising to CNY 2,238,451,691.93 in Q1 2021 from CNY 1,893,757,595.87 in Q1 2020, reflecting a growth of about 18.2%[27] Revenue and Sales - Total operating revenue for Q1 2021 reached CNY 1,547,218,556.09, a significant increase from CNY 1,149,265,438.78 in Q1 2020, representing a growth of approximately 35%[29] - The company’s sales revenue from goods and services in Q1 2021 was CNY 1,175,491,338.21, up from CNY 1,042,326,710.60 in Q1 2020, reflecting a growth of 12.7%[36] Assets and Liabilities - Total assets increased by 11.32% to CNY 6,918,494,066.61 compared to the end of the previous year[8] - Total liabilities increased to CNY 1,164,086,525.12, up from ¥805,730,882.51 in the previous year, reflecting higher accounts payable and short-term borrowings[22] - Total assets as of March 31, 2021, amounted to CNY 6,258,284,024.89, compared to CNY 5,796,993,455.18 at the end of 2020, indicating an increase of about 8%[27] - Total liabilities increased to CNY 876,174,215.15 in Q1 2021 from CNY 758,322,164.68 in Q1 2020, reflecting a growth of approximately 15.6%[27] Cash Flow - Net cash flow from operating activities was CNY 142,089,640.65, a significant recovery from a negative cash flow of CNY -81,227,292.61 in the previous year[8] - The company's cash flow from operating activities improved significantly, with a net inflow of ¥142,089,640.65, an increase of ¥223,316,933.26 compared to the previous year[19] - In Q1 2021, the company's operating cash inflow was CNY 1,182,550,178.93, an increase of 12.5% compared to CNY 1,050,823,721.88 in Q1 2020[36] - The total cash outflow for operating activities was CNY 1,040,460,538.28, a decrease of 8.1% from CNY 1,132,051,014.49 in the previous year[36] Investment and R&D - Research and development expenses increased by 39.64% to ¥28,912,711.90, reflecting the company's commitment to enhancing R&D efforts[17] - The company reported a significant increase in investment income, which rose by 701.91% to ¥80,424,071.81, attributed to improved profits from joint ventures[17] - The company invested CNY 304,957,540.90 in fixed assets and other long-term assets in Q1 2021, significantly higher than CNY 44,017,308.52 in Q1 2020[37] Shareholder Information - The number of shareholders reached 78,526 at the end of the reporting period[12] - The largest shareholder, Shanghai Huayi (Group) Company, holds 46.59% of the shares[12] Market Strategy - The company is focusing on expanding its market presence and enhancing product development strategies to drive future growth[28] - The company plans to continue investing in new technologies and potential acquisitions to strengthen its competitive position in the market[28]